T. Crabtree
Papers
1
Total Citations
1
H-Index
1
About
Dr. T. Crabtree is a radiation oncologist whose research focuses on optimizing stereotactic body radiation therapy (SBRT) for prostate cancer, particularly through dose escalation and risk stratification. Their most cited work, a 2023 study on extreme dose-escalated SBRT for intermediate-risk prostate cancer, investigates long-term relapse risk factors over a decade, probing whether de-intensification is feasible for unfavorable patient subgroups. This contribution addresses a critical clinical dilemma: balancing aggressive treatment to prevent recurrence against potential overtreatment and toxicity. While the paper has garnered 1 citation to date, its forward-looking question—whether we can safely reduce therapy intensity in select patients—positions Dr. Crabtree at the forefront of personalized radiotherapy. Their research directly impacts treatment de-escalation strategies, aiming to improve quality of life without compromising oncologic outcomes. Dr. Crabtree’s work exemplifies the shift toward precision oncology, where long-term follow-up data guide nuanced decisions for intermediate-risk prostate cancer patients.
Research Focus
Key Achievements
Top Papers
- 1